Humanwell Healthcare Group Co Ltd
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more
Humanwell Healthcare Group Co Ltd (600079) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.048x
Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has a cash flow conversion efficiency ratio of 0.048x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥903.00 Million) by net assets (CN¥18.96 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Humanwell Healthcare Group Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2024)
This chart illustrates how Humanwell Healthcare Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Humanwell Healthcare Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Brady Corporation
NYSE:BRC
|
0.041x |
|
Kobe Bussan Co. Ltd.
PINK:KOBNF
|
0.018x |
|
Post Holdings Inc
NYSE:POST
|
0.068x |
|
TIS Inc
F:4HO
|
N/A |
|
Veren Inc
NYSE:VRN
|
0.076x |
|
Rongsheng Petrochemical Co Ltd
SHE:002493
|
0.167x |
|
Soochow Securities Co Ltd
SHG:601555
|
0.336x |
|
PBF Energy Inc
NYSE:PBF
|
0.005x |
Annual Cash Flow Conversion Efficiency for Humanwell Healthcare Group Co Ltd (2000–2024)
The table below shows the annual cash flow conversion efficiency of Humanwell Healthcare Group Co Ltd from 2000 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥20.69 Billion | CN¥2.16 Billion | 0.105x | +6.85% |
| 2023-12-31 | CN¥20.10 Billion | CN¥1.97 Billion | 0.098x | -28.06% |
| 2022-12-31 | CN¥17.94 Billion | CN¥2.44 Billion | 0.136x | -2.28% |
| 2021-12-31 | CN¥15.65 Billion | CN¥2.18 Billion | 0.139x | -13.81% |
| 2020-12-31 | CN¥12.94 Billion | CN¥2.09 Billion | 0.162x | +10.95% |
| 2019-12-31 | CN¥14.00 Billion | CN¥2.04 Billion | 0.146x | +244.59% |
| 2018-12-31 | CN¥14.27 Billion | CN¥602.99 Million | 0.042x | +651.64% |
| 2017-12-31 | CN¥16.61 Billion | CN¥93.35 Million | 0.006x | -87.21% |
| 2016-12-31 | CN¥11.98 Billion | CN¥526.48 Million | 0.044x | +29.63% |
| 2015-12-31 | CN¥9.18 Billion | CN¥311.22 Million | 0.034x | -61.38% |
| 2014-12-31 | CN¥5.73 Billion | CN¥502.70 Million | 0.088x | -10.50% |
| 2013-12-31 | CN¥5.08 Billion | CN¥498.22 Million | 0.098x | +107.76% |
| 2012-12-31 | CN¥3.65 Billion | CN¥172.27 Million | 0.047x | +57.24% |
| 2011-12-31 | CN¥3.14 Billion | CN¥94.23 Million | 0.030x | -37.27% |
| 2010-12-31 | CN¥2.33 Billion | CN¥111.39 Million | 0.048x | -35.55% |
| 2009-12-31 | CN¥2.08 Billion | CN¥154.51 Million | 0.074x | +163.33% |
| 2008-12-31 | CN¥1.24 Billion | CN¥34.97 Million | 0.028x | -40.22% |
| 2007-12-31 | CN¥1.17 Billion | CN¥55.05 Million | 0.047x | -38.05% |
| 2006-12-31 | CN¥1.11 Billion | CN¥84.44 Million | 0.076x | -53.95% |
| 2005-12-31 | CN¥768.89 Million | CN¥127.13 Million | 0.165x | +69.80% |
| 2004-12-31 | CN¥724.52 Million | CN¥70.55 Million | 0.097x | +37.38% |
| 2003-12-31 | CN¥681.54 Million | CN¥48.31 Million | 0.071x | +66.56% |
| 2001-12-31 | CN¥396.54 Million | CN¥16.88 Million | 0.043x | -47.20% |
| 2000-12-31 | CN¥325.09 Million | CN¥26.20 Million | 0.081x | -- |